Award-winning Austrian supplement containing "spermidine" is now available to consumers in the US
DENVER, Sept. 9, 2020 /PRNewswire/ -- TLL The Longevity Labs GmbH, an Austrian-based life sciences company, and its wholly-owned, US subsidiary, Longevity Labs Inc., announce the market-launch of sales in the US of its award-winning dietary supplement, spermidineLIFE®. spermidineLIFE® is the world's first naturally extracted and clinically tested dietary supplement to promote cellular renewal. The active ingredient, spermidine, is considered key to slowing down the cellular aging process.
Until recently, fasting has been considered the most efficient method to trigger the critical cellular renewal process, called "autophagy;" however, European aging scientists have discovered that autophagy is also triggered through a substance found in the human body, called spermidine. As the body ages, spermidine levels decrease, along with the self-renewing power of its cells. In search of a way to offset the effects of decreasing spermidine levels, Longevity Labs developed a method to isolate spermidine from plants (wheat germ) and to make it available to humans as a dietary supplement - spermidineLIFE®.
TLL The Longevity Labs GmbH ("TLL") launched its first flagship product, spermidineLIFE® in the EU 2019, bringing the first commercially available, safety-tested, lab-verified, spermidine-rich supplement to the global market. Quickly becoming a phenomenon in Austria and Germany, in September 2020, TLL has begun distribution of spermidineLIFE® in the United States, through its subsidiary, Longevity Labs Inc., via its US website at www.spermidinelife.us.
"We began with a common vision to support healthy aging. Spermidine was completely unknown in Austria but the scientific research, quality of our product and its effectiveness convinced the public. spermidineLIFE® was voted one of the top 3 OTC product innovations in Austria in 2019 and interest has only continued to grow worldwide," says Vedran Bijelac, CEO of Longevity Labs Inc and Director of Sales and Marketing of TLL.
"We are proud to be the first scientifically tested and naturally-extracted spermidine supplement," says Daniel Dietz, COO of Longevity Labs Inc. "Not only do we want to present the health benefits of spermidine to the American population, we also want to find additional research partners. We are already working with more than 10 research institutions in Europe but the opportunity to work with top US scientists is very exciting."
spermidineLIFE® is naturally extracted from European non-GMO wheat germ using TLL's proprietary extraction process in its state-of-the-art manufacturing facility in Graz, Austria. spermidineLIFE® is lab-tested to ensure consistently rich spermidine content and has been tested for safety and tolerability in humans.
spermidineLIFE® is available to consumers via its website via a monthly subscription model starting at $99. The supplement will also be available for one or more monthly package orders starting at $109. Wholesale pricing is available for practitioners.
For additional information or questions, please contact [email protected].
For more information about spermidineLIFE® or to place an order, please visit www.spermidinelife.us.
About TLL The Longevity Labs, GmbH
TLL The Longevity Labs, GmbH is based in Graz, Austria. With the goal of translating scientific findings into natural solutions for a longer and healthier life, TLL worked with european university research partners to develop its novel product spermidineLIFE®, with EU sales launching in 2019 and expanding worldwide. TLL continues to perform best-in-class research on life-extending products and services to bring to the global marketplace. For more information, visit www.spermidinelife.com (global) or www.spermidinelife.us (United States).
No governmental agency has reviewed, approved or disapproved the content of this news release.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
SOURCE Longevity Labs Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article